Rolf Barth to Immunosuppressive Agents
This is a "connection" page, showing publications Rolf Barth has written about Immunosuppressive Agents.
Connection Strength
2.089
-
Pig-to-baboon liver xenoperfusion utilizing GalTKO.hCD46 pigs and glycoprotein Ib blockade. Xenotransplantation. 2014 May-Jun; 21(3):274-86.
Score: 0.321
-
Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation. 2014 Jan 27; 97(2):133-7.
Score: 0.318
-
Transplantation: The promise of co-stimulatory blockade in transplantation. Nat Rev Nephrol. 2013 Apr; 9(4):189-90.
Score: 0.299
-
Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. Transplantation. 2009 Dec 15; 88(11):1242-50.
Score: 0.239
-
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int. 2006 Nov; 19(11):885-92.
Score: 0.192
-
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts. Clin Transplant. 2019 06; 33(6):e13531.
Score: 0.114
-
Regulatory T cells are not predictive of outcomes in a nonhuman primate model of vascularized composite allotransplantation. Transplantation. 2013 Aug 15; 96(3):267-73.
Score: 0.077
-
Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Transplantation. 2013 May 27; 95(10):1204-10.
Score: 0.076
-
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transplant. 2011 Jul; 11(7):1407-16.
Score: 0.066
-
Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients. Transplantation. 2009 May 27; 87(10):1549-54.
Score: 0.057
-
Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival. Plast Reconstr Surg. 2009 Feb; 123(2):493-501.
Score: 0.056
-
Impact of Renal Replacement Therapy on Rejection among Liver Transplant Recipients. Prog Transplant. 2023 Dec; 33(4):348-355.
Score: 0.039
-
Impact of Steroid Only Induction on Rejection in Simultaneous Liver-Kidney Transplantation. Prog Transplant. 2022 12; 32(4):363-369.
Score: 0.036
-
Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. Transplantation. 2001 May 27; 71(10):1368-79.
Score: 0.033
-
Tolerance across a two-haplotype, fully MHC-mismatched barrier induced in miniature swine renal allografts treated with a 12-day course of tacrolimus. Transplant Proc. 2001 Feb-Mar; 33(1-2):101.
Score: 0.032
-
Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience. J Pharm Pract. 2021 Apr; 34(2):199-206.
Score: 0.029
-
Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts. Transpl Int. 2014 Sep; 27(9):966-76.
Score: 0.020
-
Facial transplantation: the first 9 years. Lancet. 2014 Dec 13; 384(9960):2153-63.
Score: 0.020
-
Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB (Oxford). 2010 Dec; 12(10):657-63.
Score: 0.016
-
Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant. 2010 Jul; 10(7):1660-7.
Score: 0.015
-
The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation. 2009 Mar 27; 87(6):805-12.
Score: 0.014
-
Annual literature review for clinical transplants 2005. Clin Transpl. 2005; 311-32.
Score: 0.011
-
Miniature swine and hDAF pig kidney transplantation in baboons treated with a nonmyeloablative regimen and CD154 blockade. Transplant Proc. 2001 Feb-Mar; 33(1-2):716.
Score: 0.008